Talcum Powder Cancer Lawsuit

Johnson & Johnson's Asbestos Testing Methods are Considered Substandard By Testing Industry Experts

Johnson & Johnson has tested only a microscopically small percentage of the talc they have sold

Wednesday, September 16, 2020 - The controversy over talc testing methods continues to be the lynchpin for thousands of plaintiffs that have filed suit claiming that Johnson's Baby Powder or other cosmetic products made from talc contain asbestos and caused their ovarian cancer or mesothelioma. Johnson & Johnson's defense of talc, the main ingredient in their iconic brand of baby powder, is based on their claim that the company has adequately tested the product over the years and have never found asbestos or other health-damaging fibers. Microscope research scientists working for plaintiffs and also for the US Food and Drug Administration (FDA) have discovered Johnson's Baby Powder to contain asbestos and also other health hazardous elongated fibers that experts have testified may lead to cancer. Johnson & Johnson argue that those testing methods are too sensitive and that the elongated fibers in talc are not proven to cause cancer. Talcum powder cancer lawsuits are represented by top national attorneys offering a free no obligation consultation before filing a claim.

The plaintiffs contend that the testing method that Johnson & Johnson and the cosmetics industry as a whole has used to test talc since 1970 when asbestos contamination first came into the limelight is insensitive to the point as to guarantee that no asbestos or other fibers could be found. Microscope researchers like Dr. William Longo testifying for plaintiffs say that Johnson & Johnson has tested only a microscopically small percentage of the talc they have sold while asbestos has been found in many independent tests cited by the plaintiffs suing the company. The US House Committee on Oversight and Reform summed up Dr. Longo's sworn testimony by saying, "Dr. William Longo testified that decades of talc-based Johnson & Johnson Baby Powder samples tested positive for asbestos detection when more sensitive asbestos detection methods were utilized." Dr. Longo's written testimony on December 19, 2019, to Raja Krishnamoorthi Chairman Subcommittee on Economic and Consumer Policy stated not only had his and other credible testing services found asbestos, but that Johnson & Johnson's testing methods are inadequate. Dr. Longo wrote: "Independent labs throughout the country and over the course of several decades have documented the presence of asbestos in consumer talcum products including Johnson's Baby Powder. AMA Analytical, Forensic Analytical, MVA Scientific Consultants, our own lab MAS, and Johnson & Johnson's own consultants - Colorado School of Mines, Dartmouth University, McCrone Associates, Rutgers University, The RJ Lee Group (and others) have all documented asbestos in Johnson's and other manufacturers' talcum products over the course of decades. The cosmetic talc industry has, in that time, accumulated hundreds, if not thousands of testing results that report "no detectable or quantifiable asbestos. These reports, regarded by the manufactures as "negative," are very misleading as they result from analytical and methodological techniques with poor detection limits."

In addition to Johnson's Baby Powder, the beauty products that have tested positive for asbestos are Beauty Plus Global, Inc. City Color Timeless Beauty Palette, Beauty Plus Global, Inc. City Color Matte Blush (Fuchsia), Beauty Plus Global, Inc. City Color Shimmer Bronzer (Caramel), and Beauty Plus Global, Inc. City Color Bronzer (Sunset), according to the "FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics for Asbestiform Fibers by AMA Laboratories During FY19."

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.